Roth Capital Assumes BioRestorative Therapies Inc. (BRTX) at Buy, PT $15

Go back to Roth Capital Assumes BioRestorative Therapies Inc. (BRTX) at Buy, PT $15

Biorestorative Therapies (BRTX) Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication

December 6, 2022 7:04 AM EST

Non-Dilutive Grant Funding to Support Development of Brown Adipose-Based Therapeutic Programs Directed at Polycystic... More